NASDAQ:STAA - STAAR Surgical Stock Price, Forecast & News

STAAR Surgical trades on the NASDAQ under the ticker symbol "STAA."

STAAR Surgical (NASDAQ:STAA) posted its earnings results on Wednesday, October, 30th. The medical instruments supplier reported $0.05 earnings per share for the quarter, meeting the Thomson Reuters' consensus estimate of $0.05. The medical instruments supplier had revenue of $39.06 million for the quarter, compared to analyst estimates of $37.50 million. STAAR Surgical had a net margin of 6.15% and a return on equity of 13.84%. View STAAR Surgical's Earnings History.

STAAR Surgical is scheduled to release their next quarterly earnings announcement on Thursday, February 20th 2020. View Earnings Estimates for STAAR Surgical.

STAAR Surgical issued an update on its FY 2019 Pre-Market earnings guidance on Monday, January, 13th. The company provided earnings per share guidance of for the period. The company issued revenue guidance of $150.2-150.2 million, compared to the consensus revenue estimate of $149.45 million.

3 equities research analysts have issued 1-year price targets for STAAR Surgical's stock. Their forecasts range from $45.00 to $56.00. On average, they anticipate STAAR Surgical's stock price to reach $49.00 in the next twelve months. This suggests a possible upside of 15.7% from the stock's current price. View Analyst Price Targets for STAAR Surgical.

3 Wall Street analysts have issued "buy," "hold," and "sell" ratings for STAAR Surgical in the last year. There are currently 3 buy ratings for the stock, resulting in a consensus recommendation of "Buy." View Analyst Ratings for STAAR Surgical.

Press coverage about STAA stock has been trending negative this week, InfoTrie Sentiment reports. InfoTrie identifies positive and negative media coverage by monitoring more than six thousand blog and news sources. The firm ranks coverage of companies on a scale of negative five to five, with scores closest to five being the most favorable. STAAR Surgical earned a media sentiment score of -2.3 on InfoTrie's scale. They also gave media stories about the medical instruments supplier a news buzz of 0.0 out of 10, meaning that recent media coverage is extremely unlikely to have an effect on the company's share price in the near future. View News Stories for STAAR Surgical.

STAAR Surgical saw a decline in short interest during the month of December. As of December 31st, there was short interest totalling 3,950,000 shares, a decline of 7.7% from the December 15th total of 4,280,000 shares. Based on an average trading volume of 373,500 shares, the days-to-cover ratio is currently 10.6 days. Currently, 9.0% of the shares of the company are short sold. View STAAR Surgical's Current Options Chain.

Some companies that are related to STAAR Surgical include Align Technology (ALGN), Cooper Companies (COO), DENTSPLY SIRONA (XRAY), West Pharmaceutical Services (WST), Haemonetics (HAE), ICU Medical (ICUI), Neogen (NEOG), Quidel (QDEL), Merit Medical Systems (MMSI), Atrion (ATRI), Antares Pharma (ATRS), Anika Therapeutics (ANIK), Cerus (CERS), OraSure Technologies (OSUR) and Meridian Bioscience (VIVO).

Based on aggregate information from My MarketBeat watchlists, some companies that other STAAR Surgical investors own include NVIDIA (NVDA), TransEnterix (TRXC), Rockwell Medical (RMTI), Vanda Pharmaceuticals (VNDA), Xilinx (XLNX), Walt Disney (DIS), Verizon Communications (VZ), Adobe (ADBE), Extreme Networks (EXTR) and Immunomedics (IMMU).

STAAR Surgical's stock is owned by many different of institutional and retail investors. Top institutional investors include KAMES CAPITAL plc (0.24%), Assenagon Asset Management S.A. (0.03%), NEXT Financial Group Inc (0.01%) and Exchange Traded Concepts LLC (0.01%). Company insiders that own STAAR Surgical stock include Broadwood Partners, LP, Caren L Mason, Deborah J Andrews, Graydon C Hansen, Jon K Hayashida, Keith Holliday, Samuel J Gesten, Scott D Barnes and William P Wall. View Institutional Ownership Trends for STAAR Surgical.

STAA stock was sold by a variety of institutional investors in the last quarter, including KAMES CAPITAL plc. Company insiders that have sold STAAR Surgical company stock in the last year include Caren L Mason, Deborah J Andrews, Graydon C Hansen, Jon K Hayashida, Keith Holliday, Samuel J Gesten and Scott D Barnes. View Insider Buying and Selling for STAAR Surgical.

STAA stock was acquired by a variety of institutional investors in the last quarter, including Assenagon Asset Management S.A., Exchange Traded Concepts LLC and NEXT Financial Group Inc. View Insider Buying and Selling for STAAR Surgical.

Shares of STAA can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab.

One share of STAA stock can currently be purchased for approximately $42.36.

STAAR Surgical has a market capitalization of $1.89 billion and generates $123.95 million in revenue each year. The medical instruments supplier earns $4.97 million in net income (profit) each year or $0.28 on an earnings per share basis. STAAR Surgical employs 475 workers across the globe.View Additional Information About STAAR Surgical.

The official website for STAAR Surgical is http://www.staar.com/.

STAAR Surgical's mailing address is 25651 ATLANTIC OCEAN DRIVE, LAKE FOREST CA, 92630. The medical instruments supplier can be reached via phone at 626-303-7902 or via email at [email protected]